Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Anvisa says Covaxin producing facility does not meet CGMP standards
Denies permission to import Bharat Biotech's COVID-19 vaccine Covaxin into the country
Rossari Biotech commissions greenfield manufacturing facility at Dahej, Gujarat
The greenfield facility will have a total installed capacity 132,500 MTPA, enhancing the total capacity of Rossari by 2.1x to…
GSK Pharma board approves sale of Vemgal facility to Hetero Labs for Rs 180 crores
The transaction is expected to be completed by September 30, 2021
Piramal Pharma to acquire 100 per cent stake in Hemmo Pharma for Rs 775 crores
This acquisition marks PPS’ foray into the development and manufacturing of peptide APIs
DCGI extends shelf life of COVISHIELD: Document, sources
Now, the AstraZeneca COVID-19 vaccine can be used for up to nine months from its manufacture date
MIMS Research Foundation is developing a novel drug to treat coronavirus
The company have repurposed its sepsis research for COVID management
Zydus Cadila, Alembic Pharma recall drugs in US
Zydus Pharmaceuticals (USA) is recalling four lots of Acyclovir Sodium Injection, 50 mg/mL, 10 mL and 20 mL vials, while Alembic…
India Vaccine Inc’s Achilles heel
Vaccine manufacturers have warned that shortages of raw materials and key manufacturing equipment are slowing down production
TechInvention partners with Eubiologics to launch oral cholera vaccine in LDPE unidose pack in India
83 million doses of Cholera vaccine will be required in India by 2025
Novartis signs deal with iTheranostics to develop, commercialise compounds targeting FAP
Expands Novartis Oncology radioligand pipeline with exclusive worldwide rights to develop and commercialise therapeutic…